<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmtech.findpharma.com/pharmtech/servlet/pharmtech_full.rss">
    <title>Pharmaceutical Technology Magazine</title>

    <link>http://pharmtech.findpharma.com/pharmtech</link>

    <description>A publication providing practical information on pharmaceutical manufacturing. Content focuses on
    applied R&amp;amp;D technology, process control and computer-integrated manufacturing, biotechnology and technical
    management.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Company-and-People-Notes-AMRI-Opens-In-Vitro-Labor/ArticleStandard/Article/detail/531389?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Roche-to-Acquire-Genentech-for-437-Billion/ArticleStandard/Article/detail/531356?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Launches-Fellowship-Program/ArticleStandard/Article/detail/531337?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Reissues-Exemption-for-Phase-I-Testing/ArticleStandard/Article/detail/531236?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Teva-to-Purchase-Barr/ArticleStandard/Article/detail/531227?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Whitepaper/Developing-powder-processing-expertise-for-the-imp/ArticleStandard/Article/detail/530887?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Comments-on-ldquoePedigree-Using-the-Gift-of-Time-/ArticleStandard/Article/detail/530504?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/Draft-Guidance-Issued-for-Electronic-Regulatory-Su/ArticleStandard/Article/detail/530123?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Bristol-Myers-Squibb-Upgrades-Equipment-for-Clean-/ArticleStandard/Article/detail/530127?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Solid-Microstructured-Transdermal-Delivery-Highlig/ArticleStandard/Article/detail/530138?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-to-Cut-275-Michigan-Jobs/ArticleStandard/Article/detail/530137?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Solvay-Pharma-Raises-Bid-/ArticleStandard/Article/detail/530372?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/The-Challenges-of-Manufacturing-Nanoparticles-thro/ArticleStandard/Article/detail/529752?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/July-2008-Editors-Picks-Parker-Fluid-Control-Divis/ArticleStandard/Article/detail/529716?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/IT-Strategies-for-Evaluating-CMO-Performance/ArticleStandard/Article/detail/529783?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Final-Bulk-Inspection-of-Solid-Dose-Pharmaceutical/ArticleStandard/Article/detail/528922?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Pfizer-To-Pay-Fine-for-PharmaMACT-Violations/ArticleStandard/Article/detail/528623?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/European-Pharmacopeia-Defines-Policy-for-Potential/ArticleStandard/Article/detail/528626?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Company-and-People-Notes-Fresenius-to-Acquire-APP-/ArticleStandard/Article/detail/528672?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Opens-Pilot-Program-for-Biotech/ArticleStandard/Article/detail/528625?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/European-Pharmacopeia-Adopts-Revised-Heparin-Monog/ArticleStandard/Article/detail/528624?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Enterprise-Level-Change-Control/ArticleStandard/Article/detail/527225?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/The-Economics-of-Follow-on-Biologics/ArticleStandard/Article/detail/527183?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Comments-on-Public-Service-Versus-Self-Service/ArticleStandard/Article/detail/528678?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Toward-a-New-Model-for-Contract-Manufacturing/ArticleStandard/Article/detail/527178?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Containment-of-Basket-Filtration-Centrifuges/ArticleStandard/Article/detail/528299?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Federal-Report-Outlines-Cost-Savings-in-Biosimilar/ArticleStandard/Article/detail/527568?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Bush-Signs-Bill-Granting-FDA-150-Million/ArticleStandard/Article/detail/527573?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Wireless-Environmental-Monitoring-Solutions/ArticleStandard/Article/detail/527826?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Green-Route-for-Precursors-for-Suzuki-Coupling-Rec/ArticleStandard/Article/detail/527575?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Nanoscale-Technique-Measures-Surface-Physical-Prop/ArticleStandard/Article/detail/527577?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Schering-Plough-and-Merck/ArticleStandard/Article/detail/527655?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Testing+News/emUSPem-467-Residual-Solvents-Becomes-Official/ArticleStandard/Article/detail/527574?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Variables-Affecting-Reconstitution-Time-of-Dry-Pow/ArticleStandard/Article/detail/529175?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/A-Path-to-Quality/ArticleStandard/Article/detail/529453?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/How-to-Pay-for-it-All/ArticleStandard/Article/detail/529160?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/In+the+Spotlight/In-the-Spotlight/ArticleStandard/Article/detail/529163?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Feature+Article/Compliance-Risk-Management-Using-a-Top-Down-Valida/ArticleStandard/Article/detail/529176?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Washington+Report/Celebrating-25-Years-of-Orphan-Drugs/ArticleStandard/Article/detail/529164?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/Talked-to-Your-Peers-Lately/ArticleStandard/Article/detail/529161?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Inside+IPEC/Dual-Use-Labeling/ArticleStandard/Article/detail/529169?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/Self-Emulsifying-Drug-Delivery-Systems/ArticleStandard/Article/detail/529471?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Feature+Article/Tipping-the-Scales-in-Manufacturing-Investment/ArticleStandard/Article/detail/529173?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Viewpoint/ePedigree-Using-the-Gift-of-Time-Wisely/ArticleStandard/Article/detail/529171?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Polymers/Improved-Mass-Determination-of-Polyethylene-glycol/ArticleStandard/Article/detail/529167?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/A-Reality-Check-on-Emerging-Markets/ArticleStandard/Article/detail/529165?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Deviations-and-Delays/ArticleStandard/Article/detail/529162?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Feature+Article/The-Benefits-and-Challenges-of-PEGylating-Small-Mo/ArticleStandard/Article/detail/529168?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/In+the+Field/Report-From-The-Netherlands/ArticleStandard/Article/detail/529172?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Help-Your-Contract-Laboratory-Help-You/ArticleStandard/Article/detail/529170?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Special+Report/Manufacturing-Insights-Pfizer/ArticleStandard/Article/detail/529174?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Polymers/Excipients-in-Polymeric-Drug-Delivery-and-Formulat/ArticleStandard/Article/detail/529177?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/In+the+Field/Coming-Down-the-Pike-Protein-Substrate-Binding/ArticleStandard/Article/detail/529446?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/In+the+Field/Trends-Industry-Job-Cuts/ArticleStandard/Article/detail/529447?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Charting-API-Market-Growth-and-Opportunity/ArticleStandard/Article/detail/529166?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/House-Subcommittee-Approves-21-Billion-for-FDA/ArticleStandard/Article/detail/526064?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Company-and-People-Notes-Merck-to-Expand-North-Car/ArticleStandard/Article/detail/526093?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/USP-Posts-Revised-Heparin-Monographs/ArticleStandard/Article/detail/526062?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Study-Tests-Antibody-Coated-Nanotubes-and-NIR-Ligh/ArticleStandard/Article/detail/526059?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Bayer-Advances-Protein-Production-from-Tobacco-Pla/ArticleStandard/Article/detail/526053?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Scale-up-of-Liquid--Liquid-Centrifuges/ArticleStandard/Article/detail/525749?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/HHS-Targets-FDAs-Generic-Drug-Reviews/ArticleStandard/Article/detail/524761?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/FDA-EMEA-Consider-Seven-New-Toxicity-Tests/ArticleStandard/Article/detail/524764?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-SAFC-Biosciences-to-Colla/ArticleStandard/Article/detail/524944?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/OGD-Requires-Residual-Solvent-Data-in-ANDAs/ArticleStandard/Article/detail/524748?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Senator-Probes-into-Pharmaceutical-Outsourcing-Pra/ArticleStandard/Article/detail/524757?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Selecting-the-Best-Conveyor-for-Your-Application/ArticleStandard/Article/detail/524217?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/The-Future-of-Disposable-Containment/ArticleStandard/Article/detail/524215?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/June-2008-Editors-Picks-Esco-Technologies-and-Hawk/ArticleStandard/Article/detail/524210?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry-Employment-Factoids/ArticleStandard/Article/detail/526838?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry-Events-for-2008ndash2009/ArticleStandard/Article/detail/526786?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Approved-New-Molecular-Entities/ArticleStandard/Article/detail/526791?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Top-50-Manufacturing-Pharmaceutical-Companies/ArticleStandard/Article/detail/526833?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry-and-Trade-Associations/ArticleStandard/Article/detail/526834?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/iPharmaceutical-Technologyi-Article-Index/ArticleStandard/Article/detail/526840?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulatory-Governmental-amp-Standards-Organization/ArticleStandard/Article/detail/526835?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Company-and-People-Notes-Daiichi-Sankyo-to-Acquire/ArticleStandard/Article/detail/523195?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/ICH-Q10-Moves-to-Final-Stage-International-Adoptio/ArticleStandard/Article/detail/523172?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/EMEA-Report-Assesses-Contaminated-Heparin-Risk/ArticleStandard/Article/detail/523176?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/European-Chemicals-Agency-Begins-REACH-Implementat/ArticleStandard/Article/detail/523175?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Researcher-Disqualifications-on-the-Rise-Despite-C/ArticleStandard/Article/detail/523178?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/A-Guide-to-Near-Infrared-Spectroscopic-Analysis-of/ArticleStandard/Article/detail/523519?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-CHO-Cell-Culture-Medium-Usin/ArticleStandard/Article/detail/523510?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-line-Process-Analysis-of-Residual-Moisture-in-a/ArticleStandard/Article/detail/523514?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Monitoring-Granulation-Drying-using-Near-Infrared-/ArticleStandard/Article/detail/523516?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation/Assessing-powder-stability/ArticleStandard/Article/detail/522282?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation+News/FDA-Issues-Structured-Product-Labeling-Guidance-Sa/ArticleStandard/Article/detail/521245?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/California-Senate-Passes-Bill-That-Would-Amend-the/ArticleStandard/Article/detail/521455?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/SOCMA-Weighs-in-on-Proposed-Legislation-on-Global-/ArticleStandard/Article/detail/521466?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Urges-Early-Switch-to-HFA-Propelled-Albuterol-/ArticleStandard/Article/detail/521242?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-to-Acquire-Kosan-L-Pa/ArticleStandard/Article/detail/521822?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-EMEA-and-European-Commission-Set-First-Goals-i/ArticleStandard/Article/detail/521462?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/European-Commission-Seeks-to-Tighten-the-API-Suppl/ArticleStandard/Article/detail/519118?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/CMOs-are-Planning-for-the-Last-War/ArticleStandard/Article/detail/519119?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Global-and-US-Biotech-Markets-Show-Strength/ArticleStandard/Article/detail/519117?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/Innovations-at-INTERPHEX-Part-2/ArticleStandard/Article/detail/522137?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/Public-Service-Versus-Self-Service/ArticleStandard/Article/detail/522123?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/PDA-Takes-On-Risks-for-Patients/ArticleStandard/Article/detail/522124?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/The-Use-of-Complaining/ArticleStandard/Article/detail/522125?ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2008-07-23T20:57:38Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Company-and-People-Notes-AMRI-Opens-In-Vitro-Labor/ArticleStandard/Article/detail/531389?ref=25">

    <title>Company and People Notes: AMRI Opens In Vitro Laboratory in Singapore; Bristol-Myers Squibb Names Quentin
    Roach Senior Vice-President and Chief Procurement Officer, More ...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Company-and-People-Notes-AMRI-Opens-In-Vitro-Labor/ArticleStandard/Article/detail/531389?ref=25</link>

    <description>Also, Niro changes its name to GEA Process Engineering; Frances K. Heller joins Exelixis as executive
    vice-president of business development, more...</description>

    <dc:date>2008-07-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302008/531389null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Roche-to-Acquire-Genentech-for-437-Billion/ArticleStandard/Article/detail/531356?ref=25">

    <title>Roche to Acquire Genentech for $43.7 Billion</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Roche-to-Acquire-Genentech-for-437-Billion/ArticleStandard/Article/detail/531356?ref=25</link>

    <description>Roche plans to acquire the biopharmaceutical company Genentech (South San Francisco, CA) for $43.7
    billion. Roche currently holds a 55.9% stake in Genentech and it plans to acquire the remaining publicly held
    minority interest that it does not own for $89 per share.</description>

    <dc:date>2008-07-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302008/531356null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Launches-Fellowship-Program/ArticleStandard/Article/detail/531337?ref=25">

    <title>FDA Launches Fellowship Program</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Launches-Fellowship-Program/ArticleStandard/Article/detail/531337?ref=25</link>

    <description>The US Food and Drug Administration seeks applicants for its new Commissioner&amp;amp;rsquo;s
    Fellowship Program for scientists, engineers, and health professionals. The two-year program will help prepare the
    agency to replace a large number of FDA staff who are preparing to retire as well as meet future
    goals.</description>

    <dc:date>2008-07-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302008/531337null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Reissues-Exemption-for-Phase-I-Testing/ArticleStandard/Article/detail/531236?ref=25">

    <title>FDA Reissues Exemption for Phase I Testing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Reissues-Exemption-for-Phase-I-Testing/ArticleStandard/Article/detail/531236?ref=25</link>

    <description>The US Food and Drug Administration issued a final rule on July 18 that exempts early Phase I
    investigational drugs from certain good manufacturing practice regulations.</description>

    <dc:date>2008-07-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302008/531236null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Teva-to-Purchase-Barr/ArticleStandard/Article/detail/531227?ref=25">

    <title>Teva to Purchase Barr</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Teva-to-Purchase-Barr/ArticleStandard/Article/detail/531227?ref=25</link>

    <description>Teva Pharmaceutical Industries and Barr Pharmaceuticals (Montvale, NJ) signed a definitive agreement
    under which Teva will acquire Barr, the fourth-largest generic-drug company in the world. Teva will buy each share
    of Barr common stock for $39.90 in cash and 0.6272 Teva shares. Based on the closing price of Teva?s shares on July
    16, 2008, the price per share of Barr common stock is $66.50, and the total value of the acquisition is $7.46
    billion. Teva will assume Barr?s outstanding net debt of approximately $1.5 billion.</description>

    <dc:date>2008-07-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302008/531227null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Whitepaper/Developing-powder-processing-expertise-for-the-imp/ArticleStandard/Article/detail/530887?ref=25">

    <title>Developing powder processing expertise for the implementation of Quality by Design</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Whitepaper/Developing-powder-processing-expertise-for-the-imp/ArticleStandard/Article/detail/530887?ref=25</link>

    <description>Powder characterization techniques have improved significantly in recent decades, developing well
    beyond the simplistic methods traditionally used. This paper examines the changes in approach encouraged by QbD and
    the contribution modern powder testers can make.</description>

    <dc:date>2008-07-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302008/530887null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Comments-on-ldquoePedigree-Using-the-Gift-of-Time-/ArticleStandard/Article/detail/530504?ref=25">

    <title>Comments on &amp;amp;ldquo;ePedigree: Using the Gift of Time Wisely&amp;amp;rdquo;</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Comments-on-ldquoePedigree-Using-the-Gift-of-Time-/ArticleStandard/Article/detail/530504?ref=25</link>

    <description>See reader comments on PharmTech's July 2008 Viewpoint article, &amp;#34;ePedigree: Using the Gift of
    Time Wisely.&amp;#34;</description>

    <dc:date>2008-07-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/530504null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/Draft-Guidance-Issued-for-Electronic-Regulatory-Su/ArticleStandard/Article/detail/530123?ref=25">

    <title>Draft Guidance Issued for Electronic Regulatory Submission</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/Draft-Guidance-Issued-for-Electronic-Regulatory-Su/ArticleStandard/Article/detail/530123?ref=25</link>

    <description>The US Food and Drug Administration published a Draft Guidance for Industry on Providing Regulatory
    Submissions in Electronic Format in the Federal Register on July 11.</description>

    <dc:date>2008-07-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/530123null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Bristol-Myers-Squibb-Upgrades-Equipment-for-Clean-/ArticleStandard/Article/detail/530127?ref=25">

    <title>Bristol-Myers Squibb Upgrades Equipment for Clean Air Act Compliance</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Bristol-Myers-Squibb-Upgrades-Equipment-for-Clean-/ArticleStandard/Article/detail/530127?ref=25</link>

    <description>Bristol-Myers Squibb (BMS) agreed to reduce the output of ozone-depleting refrigerants at several
    industrial facilities around the country to resolve violations of the Clean Air Act. The company's modifications
    will cost approximately $3.65 million.</description>

    <dc:date>2008-07-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/530127null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Solid-Microstructured-Transdermal-Delivery-Highlig/ArticleStandard/Article/detail/530138?ref=25">

    <title>Solid Microstructured Transdermal Delivery Highlighted at Controlled Release Society's Meeting</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Solid-Microstructured-Transdermal-Delivery-Highlig/ArticleStandard/Article/detail/530138?ref=25</link>

    <description>3M Drug Delivery Systems has successfully designed a proof of concept device using a solid
    microstructured transdermal system for the systemic delivery of high-potency pharmaceuticals. The technology was
    showcased at a poster session at the annual meeting of the Controlled Release Society held this week in New York
    City.</description>

    <dc:date>2008-07-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/530138null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-to-Cut-275-Michigan-Jobs/ArticleStandard/Article/detail/530137?ref=25">

    <title>Pfizer to Cut 275 Michigan Jobs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-to-Cut-275-Michigan-Jobs/ArticleStandard/Article/detail/530137?ref=25</link>

    <description>Pfizer (New York, NY) announced plans to restructure staff at its Kalamazoo, Michigan, facility,
    leading to an estimated job cut of 275 by the end of the year.</description>

    <dc:date>2008-07-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/530137null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Solvay-Pharma-Raises-Bid-/ArticleStandard/Article/detail/530372?ref=25">

    <title>Company and People Notes: Solvay Pharma Raises Bid for Innogenetics, Catalent Appoints VP of Printed
    Components, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Solvay-Pharma-Raises-Bid-/ArticleStandard/Article/detail/530372?ref=25</link>

    <description>Also, Roche to end HIV/AIDS research program, WuXi PharmaTech makes appointments,
    more...</description>

    <dc:date>2008-07-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/530372null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/The-Challenges-of-Manufacturing-Nanoparticles-thro/ArticleStandard/Article/detail/529752?ref=25">

    <title>The Challenges of Manufacturing Nanoparticles through Media Milling</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/The-Challenges-of-Manufacturing-Nanoparticles-thro/ArticleStandard/Article/detail/529752?ref=25</link>

    <description>Creating nanoparticles can be challenging and requires appropriate equipment and techniques. Media
    milling or grinding is the best-established manufacturing method for nanoparticle production.</description>

    <dc:date>2008-07-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529752null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/July-2008-Editors-Picks-Parker-Fluid-Control-Divis/ArticleStandard/Article/detail/529716?ref=25">

    <title>July 2008 Editor's Picks: Parker Fluid Control Division and Watson-Marlow Bredel</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/July-2008-Editors-Picks-Parker-Fluid-Control-Divis/ArticleStandard/Article/detail/529716?ref=25</link>

    <description>PharmTech's monthly newsletter, Equipment &amp;amp;amp; Processing Report, reviews the Editor's Picks
    for the July 2008 edition from Parker Fluid Control Division and Watson-Marlow Bredel.</description>

    <dc:date>2008-07-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529716null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/IT-Strategies-for-Evaluating-CMO-Performance/ArticleStandard/Article/detail/529783?ref=25">

    <title>IT Strategies for Evaluating CMO Performance</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/IT-Strategies-for-Evaluating-CMO-Performance/ArticleStandard/Article/detail/529783?ref=25</link>

    <description>A pharmaceutical company's information-technology infrastructure could facilitate the appraisal of the
    performance of contract manufacturing organizations.</description>

    <dc:date>2008-07-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529783null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Final-Bulk-Inspection-of-Solid-Dose-Pharmaceutical/ArticleStandard/Article/detail/528922?ref=25">

    <title>Final Bulk Inspection of Solid-Dose Pharmaceuticals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Final-Bulk-Inspection-of-Solid-Dose-Pharmaceutical/ArticleStandard/Article/detail/528922?ref=25</link>

    <description>Final bulk inspection of solid-dose OTC and regulated pharmaceuticals must deliver consistently high
    product quality. Customers scrutinize products closely, and processes are increasingly coming under the review of
    regulatory agencies. Advanced technology addresses these challenges, as new automated continuous inspection systems
    are more effective and commercially viable than ever before.</description>

    <dc:date>2008-07-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528922null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Pfizer-To-Pay-Fine-for-PharmaMACT-Violations/ArticleStandard/Article/detail/528623?ref=25">

    <title>Pfizer To Pay Fine for PharmaMACT Violations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Pfizer-To-Pay-Fine-for-PharmaMACT-Violations/ArticleStandard/Article/detail/528623?ref=25</link>

    <description>Pfizer has agreed to pay $975,000 in civil penalties to resolve alleged violations of the Clean Air
    Act at its former manufacturing plant in Groton, Connecticut, according to a release by the US Department of
    Justice.</description>

    <dc:date>2008-07-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528623null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/European-Pharmacopeia-Defines-Policy-for-Potential/ArticleStandard/Article/detail/528626?ref=25">

    <title>European Pharmacopeia Defines Policy for Potentially Genotoxic Impurities</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/European-Pharmacopeia-Defines-Policy-for-Potential/ArticleStandard/Article/detail/528626?ref=25</link>

    <description>The European Pharmacopeia Commission has published the General Information chapter
    &amp;#34;Potentially Genotoxic Impurities and European Pharmacopoeia Monographs on Substances for Human
    Use&amp;#34; in the July 2008 edition of PharmEuropa.</description>

    <dc:date>2008-07-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528626null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Company-and-People-Notes-Fresenius-to-Acquire-APP-/ArticleStandard/Article/detail/528672?ref=25">

    <title>Company and People Notes: Fresenius to Acquire APP Pharmaceuticals, Arete Therapeutics Appoints James Sabry
    President and CEO, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Company-and-People-Notes-Fresenius-to-Acquire-APP-/ArticleStandard/Article/detail/528672?ref=25</link>

    <description>Also, Catalent Pharma Solutions to collaborate with One World Design and Manufacturing Group, Bioheart
    appoints Howard J. Leonhardt as CEO, more...</description>

    <dc:date>2008-07-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528672null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Opens-Pilot-Program-for-Biotech/ArticleStandard/Article/detail/528625?ref=25">

    <title>FDA Opens Pilot Program for Biotech</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Opens-Pilot-Program-for-Biotech/ArticleStandard/Article/detail/528625?ref=25</link>

    <description>The US Food and Drug Administration is seeking volunteers from the pharmaceutical industry to
    participate in a pilot program involving the submission of quality information for biotechnology
    products.</description>

    <dc:date>2008-07-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528625null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/European-Pharmacopeia-Adopts-Revised-Heparin-Monog/ArticleStandard/Article/detail/528624?ref=25">

    <title>European Pharmacopeia Adopts Revised Heparin Monographs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/European-Pharmacopeia-Adopts-Revised-Heparin-Monog/ArticleStandard/Article/detail/528624?ref=25</link>

    <description>The European Pharmacopoeia Commission adopted revised monographs for heparin calcium and heparin
    sodium to strengthen the level of testing required for quality control.</description>

    <dc:date>2008-07-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528624null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Enterprise-Level-Change-Control/ArticleStandard/Article/detail/527225?ref=25">

    <title>Enterprise-Level Change Control</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Enterprise-Level-Change-Control/ArticleStandard/Article/detail/527225?ref=25</link>

    <description>Change control in life-sciences organizations is a critical business issue in terms of risk, safety,
    and performance. The author examines common shortcomings in change control when implementing non-enterprise
    solutions and the functionality derived from enterprise-level change control.</description>

    <dc:date>2008-07-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527225null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/The-Economics-of-Follow-on-Biologics/ArticleStandard/Article/detail/527183?ref=25">

    <title>The Economics of Follow-on Biologics</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/The-Economics-of-Follow-on-Biologics/ArticleStandard/Article/detail/527183?ref=25</link>

    <description>A recent US government study shows that follow-on biologics are likely to have a favorable economic
    impact if proposed legislation authorizing a regulatory pathway in the US is approved.</description>

    <dc:date>2008-07-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527183null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Comments-on-Public-Service-Versus-Self-Service/ArticleStandard/Article/detail/528678?ref=25">

    <title>Comments on &amp;#34;Public Service Versus Self-Service&amp;#34;</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Comments-on-Public-Service-Versus-Self-Service/ArticleStandard/Article/detail/528678?ref=25</link>

    <description>See reader comments on Editor-in-Chief Michelle Hoffman's June 2008 editorial, &amp;#34;Public Service
    Versus Self-Service.&amp;#34;</description>

    <dc:date>2008-07-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528678null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Toward-a-New-Model-for-Contract-Manufacturing/ArticleStandard/Article/detail/527178?ref=25">

    <title>Toward a New Model for Contract Manufacturing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Toward-a-New-Model-for-Contract-Manufacturing/ArticleStandard/Article/detail/527178?ref=25</link>

    <description>Global manufacturing excellence will be a game changer for CMOs that can achieve it.</description>

    <dc:date>2008-07-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527178null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Containment-of-Basket-Filtration-Centrifuges/ArticleStandard/Article/detail/528299?ref=25">

    <title>Containment of Basket Filtration Centrifuges</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Containment-of-Basket-Filtration-Centrifuges/ArticleStandard/Article/detail/528299?ref=25</link>

    <description>Basket filtration centrifuges are commonly used as a means of filtering potent compounds, and are an
    effective way to separate and purify solid products. As the demands to minimize operator exposure to the products
    increase, and as the exposure limits to solvent vapors decrease, the challenge with basket filtration centrifuges
    is to maintain contained transfer of the caked solids during discharge into downstream processing
    equipment.</description>

    <dc:date>2008-07-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/528299null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Federal-Report-Outlines-Cost-Savings-in-Biosimilar/ArticleStandard/Article/detail/527568?ref=25">

    <title>Federal Report Outlines Cost Savings in Biosimilars Approval Pathway</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Federal-Report-Outlines-Cost-Savings-in-Biosimilar/ArticleStandard/Article/detail/527568?ref=25</link>

    <description>The Congressional Budget Office has released a report that provides a picture of the financial impact
    from the enaction of S.1695, the Biologics Price Competition and Innovation Act of 2007.</description>

    <dc:date>2008-07-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527568null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Bush-Signs-Bill-Granting-FDA-150-Million/ArticleStandard/Article/detail/527573?ref=25">

    <title>Bush Signs Bill Granting FDA $150 Million</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Bush-Signs-Bill-Granting-FDA-150-Million/ArticleStandard/Article/detail/527573?ref=25</link>

    <description>President Bush signed H.R. 2642, the Supplemental Appropriations Act of 2008, which provides $150
    million to the US Food and Drug Administration for medical-safety and drug-safety activities.</description>

    <dc:date>2008-07-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527573null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Wireless-Environmental-Monitoring-Solutions/ArticleStandard/Article/detail/527826?ref=25">

    <title>Wireless Environmental Monitoring Solutions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Wireless-Environmental-Monitoring-Solutions/ArticleStandard/Article/detail/527826?ref=25</link>

    <description>This paper describes the advantages of using a wireless environmental monitoring system for measuring
    humidity and temperature parameters in manufacturing and process industries. It explains the ease of installation
    procedure and answers the safety and data security concerns that often influence a purchase decision.</description>

    <dc:date>2008-07-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527826null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Green-Route-for-Precursors-for-Suzuki-Coupling-Rec/ArticleStandard/Article/detail/527575?ref=25">

    <title>Green Route for Precursors for Suzuki Coupling Recognized</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Green-Route-for-Precursors-for-Suzuki-Coupling-Rec/ArticleStandard/Article/detail/527575?ref=25</link>

    <description>Richard E. Maleczka Jr. and Milton R. Smith III, professors of the Department of Chemistry at Michigan
    State University, were recognized by the Environmental Protection Agency's Presidential Green Chemistry Challenge
    Awards, for designing a catalytic reaction to synthesize precursors for the Suzuki-coupling reaction.</description>

    <dc:date>2008-07-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527575null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Nanoscale-Technique-Measures-Surface-Physical-Prop/ArticleStandard/Article/detail/527577?ref=25">

    <title>Nanoscale Technique Measures Surface Physical Properties of APIs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Nanoscale-Technique-Measures-Surface-Physical-Prop/ArticleStandard/Article/detail/527577?ref=25</link>

    <description>Molecular Profiles created a poster that demonstrates the efficacy of its &amp;#34;nanoPASS&amp;#34;
    (nanoscale predictive analytical screening solution) technique to characterize an active pharmaceutical
    ingredient's (API) surface energy.</description>

    <dc:date>2008-07-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527577null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Schering-Plough-and-Merck/ArticleStandard/Article/detail/527655?ref=25">

    <title>Company and People Notes: Schering-Plough and Merck Withdraw NDA and Terminate Respiratory Joint Venture,
    Cell Biosciences Names Management Team, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Schering-Plough-and-Merck/ArticleStandard/Article/detail/527655?ref=25</link>

    <description>Also, Covance and WuXi PharmaTech to form contract research joint venture in China, Covidien makes
    appointments to its Pharmaceutical Products and Imaging Solutions businesses, more...</description>

    <dc:date>2008-07-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527655null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Testing+News/emUSPem-467-Residual-Solvents-Becomes-Official/ArticleStandard/Article/detail/527574?ref=25">

    <title>USP 467, Residual Solvents Becomes Official</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Testing+News/emUSPem-467-Residual-Solvents-Becomes-Official/ArticleStandard/Article/detail/527574?ref=25</link>

    <description>After a one-year delay in its implementation, the US Pharmacopeia Chapter 467 &amp;#34;Residual
    Solvents&amp;#34; is now official.</description>

    <dc:date>2008-07-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/527574null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Variables-Affecting-Reconstitution-Time-of-Dry-Pow/ArticleStandard/Article/detail/529175?ref=25">

    <title>Variables Affecting Reconstitution Time of Dry Powder for Injection</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Variables-Affecting-Reconstitution-Time-of-Dry-Pow/ArticleStandard/Article/detail/529175?ref=25</link>

    <description>The authors describe the factors affecting reconstitution time of dry powder for injection and
    classifies them as intrinsic and extrinsic parameters.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529175null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/A-Path-to-Quality/ArticleStandard/Article/detail/529453?ref=25">

    <title>A Path to Quality and Compliance</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/A-Path-to-Quality/ArticleStandard/Article/detail/529453?ref=25</link>

    <description>A new book explains process analytical technology, drug stability, and quality.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529453/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529453null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/How-to-Pay-for-it-All/ArticleStandard/Article/detail/529160?ref=25">

    <title>How to Pay for it All?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/How-to-Pay-for-it-All/ArticleStandard/Article/detail/529160?ref=25</link>

    <description>With no economic relief in sight, industry, like all of us, is grappling with high&amp;amp;mdash;and
    new&amp;amp;mdash;costs.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529160null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/In+the+Spotlight/In-the-Spotlight/ArticleStandard/Article/detail/529163?ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/In+the+Spotlight/In-the-Spotlight/ArticleStandard/Article/detail/529163?ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529163null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Feature+Article/Compliance-Risk-Management-Using-a-Top-Down-Valida/ArticleStandard/Article/detail/529176?ref=25">

    <title>Compliance Risk Management Using a Top-Down Validation Approach</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Feature+Article/Compliance-Risk-Management-Using-a-Top-Down-Valida/ArticleStandard/Article/detail/529176?ref=25</link>

    <description>Patient safety must be the primary concern of any validation effort. The author explains how a
    risk-based approach to validation and compliance follows naturally from this premise.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529176/70_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Washington+Report/Celebrating-25-Years-of-Orphan-Drugs/ArticleStandard/Article/detail/529164?ref=25">

    <title>Celebrating 25 Years of Orphan Drugs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Washington+Report/Celebrating-25-Years-of-Orphan-Drugs/ArticleStandard/Article/detail/529164?ref=25</link>

    <description>New scientific discoveries promise to expand treatments for rare and neglected diseases.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529164null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/Talked-to-Your-Peers-Lately/ArticleStandard/Article/detail/529161?ref=25">

    <title>Talked to Your Peers Lately?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/Talked-to-Your-Peers-Lately/ArticleStandard/Article/detail/529161?ref=25</link>

    <description>Forums, blogs, and more can spark innovation.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529161null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Inside+IPEC/Dual-Use-Labeling/ArticleStandard/Article/detail/529169?ref=25">

    <title>Dual-Use Labeling</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Inside+IPEC/Dual-Use-Labeling/ArticleStandard/Article/detail/529169?ref=25</link>

    <description>Clear labels for substances that can be used as excipients, APIs, or both are critical to end-product
    use.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529169null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/Self-Emulsifying-Drug-Delivery-Systems/ArticleStandard/Article/detail/529471?ref=25">

    <title>Self-Emulsifying Drug Delivery Systems</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/Self-Emulsifying-Drug-Delivery-Systems/ArticleStandard/Article/detail/529471?ref=25</link>

    <description>This review article explains how self-emulsifying drug delivery systems can increase the solubility
    and bioavailability of poorly soluble drug.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529471/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529471null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Feature+Article/Tipping-the-Scales-in-Manufacturing-Investment/ArticleStandard/Article/detail/529173?ref=25">

    <title>Tipping the Scales in Manufacturing Investment</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Feature+Article/Tipping-the-Scales-in-Manufacturing-Investment/ArticleStandard/Article/detail/529173?ref=25</link>

    <description>The pharmaceutical majors invest in biologics production capacity as they advance restructuring
    programs and build their pipelines</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529173/40_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Viewpoint/ePedigree-Using-the-Gift-of-Time-Wisely/ArticleStandard/Article/detail/529171?ref=25">

    <title>ePedigree: Using the Gift of Time Wisely</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Viewpoint/ePedigree-Using-the-Gift-of-Time-Wisely/ArticleStandard/Article/detail/529171?ref=25</link>

    <description>The year 2011 may seem far off, but there is much to do to prepare for electronic
    pedigrees.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529171null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Polymers/Improved-Mass-Determination-of-Polyethylene-glycol/ArticleStandard/Article/detail/529167?ref=25">

    <title>Improved Mass Determination of Poly(ethylene glycols) by Electrospray Ion-Mobility Time-of-Flight Mass
    Spectrometry Coupled with Ion&amp;amp;ndash;Molecule Reactions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Polymers/Improved-Mass-Determination-of-Polyethylene-glycol/ArticleStandard/Article/detail/529167?ref=25</link>

    <description>The authors developed a method to accurately measure the average molecular weight of large
    poly(ethylene glycols) (PEGs) using ion-mobility time-of-flight mass spectrometry coupled with gas-phase
    ion&amp;amp;ndash;molecule reactions.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529167null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/A-Reality-Check-on-Emerging-Markets/ArticleStandard/Article/detail/529165?ref=25">

    <title>A Reality Check on Emerging Markets</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/A-Reality-Check-on-Emerging-Markets/ArticleStandard/Article/detail/529165?ref=25</link>

    <description>Recent reports discuss the future of pharma's emerging markets.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529165null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Deviations-and-Delays/ArticleStandard/Article/detail/529162?ref=25">

    <title>Deviations and Delays</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Deviations-and-Delays/ArticleStandard/Article/detail/529162?ref=25</link>

    <description>They may have seemed harmless at first, but these ideas took a big bite.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529162null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Feature+Article/The-Benefits-and-Challenges-of-PEGylating-Small-Mo/ArticleStandard/Article/detail/529168?ref=25">

    <title>The Benefits and Challenges of PEGylating Small Molecules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Feature+Article/The-Benefits-and-Challenges-of-PEGylating-Small-Mo/ArticleStandard/Article/detail/529168?ref=25</link>

    <description>Polyethylene glycol (PEG) conjugation is a highly effective technical and commercial strategy to
    develop macromolecules. The authors explain the benefits and process of PEGylation and how it may be applied to
    small molecules.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529168/88_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/In+the+Field/Report-From-The-Netherlands/ArticleStandard/Article/detail/529172?ref=25">

    <title>Report From: The Netherlands</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/In+the+Field/Report-From-The-Netherlands/ArticleStandard/Article/detail/529172?ref=25</link>

    <description>A growing preference for public-private patnerships is spurring innovation and technology among Dutch
    pharmaceutical companies.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529172null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Help-Your-Contract-Laboratory-Help-You/ArticleStandard/Article/detail/529170?ref=25">

    <title>Help Your Contract Laboratory Help You</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Help-Your-Contract-Laboratory-Help-You/ArticleStandard/Article/detail/529170?ref=25</link>

    <description>Providing the right information upfront may ease new requirements to assess solvent
    levels.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529170null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Special+Report/Manufacturing-Insights-Pfizer/ArticleStandard/Article/detail/529174?ref=25">

    <title>Manufacturing Insights: Pfizer</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Special+Report/Manufacturing-Insights-Pfizer/ArticleStandard/Article/detail/529174?ref=25</link>

    <description>Natale S. Ricciardi, president of Pfizer Global Manufacturing and senior vice-president of Pfizer,
    discusses the company's new manufacturing focus that features plant network optimization, increased outsourcing,
    and greater adoption of agile or lean manufacturing.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529174null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Polymers/Excipients-in-Polymeric-Drug-Delivery-and-Formulat/ArticleStandard/Article/detail/529177?ref=25">

    <title>Excipients in Polymeric Drug Delivery and Formulations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Polymers/Excipients-in-Polymeric-Drug-Delivery-and-Formulat/ArticleStandard/Article/detail/529177?ref=25</link>

    <description>A roundtable with John Doney, Jiao Yang, Hans Baer, and Elena Draganoiu.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529177null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/In+the+Field/Coming-Down-the-Pike-Protein-Substrate-Binding/ArticleStandard/Article/detail/529446?ref=25">

    <title>Coming Down the Pike: Protein-Substrate Binding</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/In+the+Field/Coming-Down-the-Pike-Protein-Substrate-Binding/ArticleStandard/Article/detail/529446?ref=25</link>

    <description>Drugmakers seeking to block the activity of a protein may have a new strategy at their
    disposal.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529446null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/In+the+Field/Trends-Industry-Job-Cuts/ArticleStandard/Article/detail/529447?ref=25">

    <title>Trends: Industry Job Cuts</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/In+the+Field/Trends-Industry-Job-Cuts/ArticleStandard/Article/detail/529447?ref=25</link>

    <description>Staff reductions are not surprising with the state of the economy and falling pharmaceutical
    sales.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292008/529447null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Charting-API-Market-Growth-and-Opportunity/ArticleStandard/Article/detail/529166?ref=25">

    <title>Charting API Market Growth and Opportunity</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Charting-API-Market-Growth-and-Opportunity/ArticleStandard/Article/detail/529166?ref=25</link>

    <description>The year 2007 was slow for approvals for new molecular entities and overall pharmaceutical industry
    growth. Big Pharma seeks relief in a growing biologics portfolio.</description>

    <dc:date>2008-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282008/529166null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/House-Subcommittee-Approves-21-Billion-for-FDA/ArticleStandard/Article/detail/526064?ref=25">

    <title>House Subcommittee Approves $2.1 Billion for FDA</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/House-Subcommittee-Approves-21-Billion-for-FDA/ArticleStandard/Article/detail/526064?ref=25</link>

    <description>The US Food and Drug Administration will have a $2.1 billion budget next year if the fiscal year 2009
    bill markup by the US House of Representatives' Agriculture Appropriations Subcommittee passes through
    Congress.</description>

    <dc:date>2008-06-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262008/526064null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Company-and-People-Notes-Merck-to-Expand-North-Car/ArticleStandard/Article/detail/526093?ref=25">

    <title>Company and People Notes: Merck to Expand North Carolina Vaccine Facility, PDI's Michael J. Marquard
    Retires, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Company-and-People-Notes-Merck-to-Expand-North-Car/ArticleStandard/Article/detail/526093?ref=25</link>

    <description>Also, Stiefel Laboratories will acquire Barrier Therapeutics, Danube Pharmaceuticals appoints Brian
    Levy COO, more...</description>

    <dc:date>2008-06-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262008/526093null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/USP-Posts-Revised-Heparin-Monographs/ArticleStandard/Article/detail/526062?ref=25">

    <title>USP Posts Revised Heparin Monographs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/USP-Posts-Revised-Heparin-Monographs/ArticleStandard/Article/detail/526062?ref=25</link>

    <description>The US Pharmacopeia (USP) posted revised monographs for heparin sodium and heparin calcium on its
    website.</description>

    <dc:date>2008-06-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262008/526062null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Study-Tests-Antibody-Coated-Nanotubes-and-NIR-Ligh/ArticleStandard/Article/detail/526059?ref=25">

    <title>Study Tests Antibody-Coated Nanotubes and NIR Light to Kill Cancer Cells</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Study-Tests-Antibody-Coated-Nanotubes-and-NIR-Ligh/ArticleStandard/Article/detail/526059?ref=25</link>

    <description>Biomedical researchers at UT Southwestern Medical Center and nanotechnology scientists at UT Dallas
    are collaborating on a study that seeks to selectively kill cancer cells using monoclonal antibodies to coat carbon
    nanotubes that heat up when exposed to near-infrared (NIR) light.</description>

    <dc:date>2008-06-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262008/526059null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Bayer-Advances-Protein-Production-from-Tobacco-Pla/ArticleStandard/Article/detail/526053?ref=25">

    <title>Bayer Advances Protein Production from Tobacco Plants</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Bayer-Advances-Protein-Production-from-Tobacco-Pla/ArticleStandard/Article/detail/526053?ref=25</link>

    <description>Bayer and its subsidiary Icon Genetics (Halle, Germany) have developed a production process to produce
    therapeutic proteins from tobacco plants.</description>

    <dc:date>2008-06-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262008/526053null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Scale-up-of-Liquid--Liquid-Centrifuges/ArticleStandard/Article/detail/525749?ref=25">

    <title>Scale-up of Liquid / Liquid Centrifuges</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Scale-up-of-Liquid--Liquid-Centrifuges/ArticleStandard/Article/detail/525749?ref=25</link>

    <description>Centrifugal contactors are one of the technologies employed for liquid / liquid separation and liquid
    / liquid extraction processes. Every liquid / liquid system has its own specific characteristics and in order to
    successfully predict behavior, testing must be performed with small scale equipment to predict industrial
    performance. Process intensification studies can be performed using laboratory scale centrifugal contactors to
    evaluate these parameters. Pilot scale testing is performed with larger equipment to perform more thorough and
    specific testing.</description>

    <dc:date>2008-06-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262008/525749null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/HHS-Targets-FDAs-Generic-Drug-Reviews/ArticleStandard/Article/detail/524761?ref=25">

    <title>HHS Targets FDA's Generic Drug Reviews</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/HHS-Targets-FDAs-Generic-Drug-Reviews/ArticleStandard/Article/detail/524761?ref=25</link>

    <description>With most deadlines missed for reviewing each abbreviated new drug application (ANDA) it receives, the
    US Food and Drug Administration is likely to take advice from the US Department of Health and Human Services (HHS)
    on how to speed up its process.</description>

    <dc:date>2008-06-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524761null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/FDA-EMEA-Consider-Seven-New-Toxicity-Tests/ArticleStandard/Article/detail/524764?ref=25">

    <title>FDA, EMEA Consider Seven New Toxicity Tests</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/FDA-EMEA-Consider-Seven-New-Toxicity-Tests/ArticleStandard/Article/detail/524764?ref=25</link>

    <description>The US Food and Drug Administration and the European Medicines Agency will collaborate in efforts that
    would allow drug companies to submit results of seven new drug-safety tests.</description>

    <dc:date>2008-06-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524764null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-SAFC-Biosciences-to-Colla/ArticleStandard/Article/detail/524944?ref=25">

    <title>Company and People Notes: SAFC Biosciences to Collaborate With Celltrion, USP Names K.V. Surendra Nath VP of
    USP-India, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-SAFC-Biosciences-to-Colla/ArticleStandard/Article/detail/524944?ref=25</link>

    <description>Also, Patheon to expand Puerto Rico facility, Creabilis Therapeutics appoints Tony Wilson CEO,
    more...</description>

    <dc:date>2008-06-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524944null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/OGD-Requires-Residual-Solvent-Data-in-ANDAs/ArticleStandard/Article/detail/524748?ref=25">

    <title>OGD Requires Residual-Solvent Data in ANDAs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/OGD-Requires-Residual-Solvent-Data-in-ANDAs/ArticleStandard/Article/detail/524748?ref=25</link>

    <description>Effective July 1, 2008, the Office of Generic Drugs (OGD) will require abbreviated new drug
    applications (ANDAs) to include data that demonstrate the manufacturer's control of residual
    solvents.</description>

    <dc:date>2008-06-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524748null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Senator-Probes-into-Pharmaceutical-Outsourcing-Pra/ArticleStandard/Article/detail/524757?ref=25">

    <title>Senator Probes into Pharmaceutical Outsourcing Practices</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Senator-Probes-into-Pharmaceutical-Outsourcing-Pra/ArticleStandard/Article/detail/524757?ref=25</link>

    <description>Senator Sherrod Brown (D-Ohio), member of the Senate Health, Education and Labor Pensions (HELP)
    Committee, is requesting additional information from the US Food and Drug Administration and the pharmaceutical
    industry, concerning the regulation and practice of outsourcing.</description>

    <dc:date>2008-06-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524757null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Selecting-the-Best-Conveyor-for-Your-Application/ArticleStandard/Article/detail/524217?ref=25">

    <title>Selecting the Best Conveyor for Your Application</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Selecting-the-Best-Conveyor-for-Your-Application/ArticleStandard/Article/detail/524217?ref=25</link>

    <description>To choose the appropriate conveying system, a pharmaceutical manufacturer needs a thorough knowledge
    of the benefits and limitations of each conveyor type. The following overview compares several types of
    systems.</description>

    <dc:date>2008-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524217null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/The-Future-of-Disposable-Containment/ArticleStandard/Article/detail/524215?ref=25">

    <title>The Future of Disposable Containment</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/The-Future-of-Disposable-Containment/ArticleStandard/Article/detail/524215?ref=25</link>

    <description>Manufacturers have stopped seeing disposable containment as an ad hoc solution, and the technology
    increasingly incorporates thoughtful design and engineering. The future promises to bring more changes and new
    applications for disposable containment technology.</description>

    <dc:date>2008-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524215null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/June-2008-Editors-Picks-Esco-Technologies-and-Hawk/ArticleStandard/Article/detail/524210?ref=25">

    <title>June 2008 Editor's Picks: Esco Technologies and Hawk Measurement</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/June-2008-Editors-Picks-Esco-Technologies-and-Hawk/ArticleStandard/Article/detail/524210?ref=25</link>

    <description>PharmTech's monthly newsletter, Equipment &amp;amp;amp; Processing Report, reviews the Editor's Picks
    for the June 2008 edition: Esco Technologies and Hawk Measurement</description>

    <dc:date>2008-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252008/524210null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry-Employment-Factoids/ArticleStandard/Article/detail/526838?ref=25">

    <title>Industry Employment Factoids</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry-Employment-Factoids/ArticleStandard/Article/detail/526838?ref=25</link>

    <description>See statistics from Pharmaceutical Technology's annual employment survey and how those compare with
    national trends.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/526838null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry-Events-for-2008ndash2009/ArticleStandard/Article/detail/526786?ref=25">

    <title>Industry Events for 2008&amp;amp;ndash;2009</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry-Events-for-2008ndash2009/ArticleStandard/Article/detail/526786?ref=25</link>

    <description>This section from PharmTech's 2008 Industry Almanac features upcoming events for 2008 and
    2009.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/526786null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Approved-New-Molecular-Entities/ArticleStandard/Article/detail/526791?ref=25">

    <title>Approved New Molecular Entities</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Approved-New-Molecular-Entities/ArticleStandard/Article/detail/526791?ref=25</link>

    <description>This section lists the approved new molecular entities from Jan. 2007 through May 2008. The company
    names, brand names, indications and molecular structures are included.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/526791null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Top-50-Manufacturing-Pharmaceutical-Companies/ArticleStandard/Article/detail/526833?ref=25">

    <title>Top 50 Manufacturing Pharmaceutical Companies</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Top-50-Manufacturing-Pharmaceutical-Companies/ArticleStandard/Article/detail/526833?ref=25</link>

    <description>This list of the top 50 pharmaceutical companies for 2007 is based on global sales. It includes each
    company's 2007 sales and shows the change from 2006.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/526833null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry-and-Trade-Associations/ArticleStandard/Article/detail/526834?ref=25">

    <title>Industry and Trade Associations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry-and-Trade-Associations/ArticleStandard/Article/detail/526834?ref=25</link>

    <description>This section provides contact information for important industry and trade associations
    worldwide.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/526834null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/iPharmaceutical-Technologyi-Article-Index/ArticleStandard/Article/detail/526840?ref=25">

    <title>Pharmaceutical Technology Article Index</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/iPharmaceutical-Technologyi-Article-Index/ArticleStandard/Article/detail/526840?ref=25</link>

    <description>The magazine's articles (June 2007 to June 2008) are listed by type and topic.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/526840null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulatory-Governmental-amp-Standards-Organization/ArticleStandard/Article/detail/526835?ref=25">

    <title>Regulatory, Governmental &amp;amp;amp; Standards Organizations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulatory-Governmental-amp-Standards-Organization/ArticleStandard/Article/detail/526835?ref=25</link>

    <description>This section provides contact information for important regulatory, governmental and standards
    organizations worldwide.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272008/526835null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Company-and-People-Notes-Daiichi-Sankyo-to-Acquire/ArticleStandard/Article/detail/523195?ref=25">

    <title>Company and People Notes: Daiichi Sankyo to Acquire a Controlling Stake in Ranbaxy, Amgen Appoints Anna S.
    Richo Senior Vice-President of Worldwide Compliance, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Company-and-People-Notes-Daiichi-Sankyo-to-Acquire/ArticleStandard/Article/detail/523195?ref=25</link>

    <description>Also, Shire voluntarily recalls ADHD patch Daytrana</description>

    <dc:date>2008-06-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523195null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/ICH-Q10-Moves-to-Final-Stage-International-Adoptio/ArticleStandard/Article/detail/523172?ref=25">

    <title>ICH Q10 Moves to Final Stage: International Adoption</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/ICH-Q10-Moves-to-Final-Stage-International-Adoptio/ArticleStandard/Article/detail/523172?ref=25</link>

    <description>The steering committee of the International Conference on Harmonization and its expert working groups
    adopted Quality Guideline Q10 &amp;#34;Quality Systems&amp;#34; last week at a meeting in Portland,
    Oregon.</description>

    <dc:date>2008-06-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523172null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/EMEA-Report-Assesses-Contaminated-Heparin-Risk/ArticleStandard/Article/detail/523176?ref=25">

    <title>EMEA Report Assesses Contaminated-Heparin Risk</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/EMEA-Report-Assesses-Contaminated-Heparin-Risk/ArticleStandard/Article/detail/523176?ref=25</link>

    <description>In an assessment report about medicinal products containing heparin, the European Medicines Agency
    (EMEA)'s Committee for Medicinal Products for Human Use (CHMP) said it could not draw firm conclusions about the
    level of risk associated with unfractionated heparins (UFH) contaminated with oversulfated chondroitin sulfate
    (OSCS). Nevertheless, CHMP recommended that contaminated lots be withdrawn completely.</description>

    <dc:date>2008-06-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523176null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/European-Chemicals-Agency-Begins-REACH-Implementat/ArticleStandard/Article/detail/523175?ref=25">

    <title>European Chemicals Agency Begins REACH Implementation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/European-Chemicals-Agency-Begins-REACH-Implementat/ArticleStandard/Article/detail/523175?ref=25</link>

    <description>The European Chemicals Agency (ECHA), the European Union regulatory body overseeing the implementation
    of the REACH (Registration, Evaluation, and Restriction of Chemicals) regulation, began full operations on June
    1.</description>

    <dc:date>2008-06-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523175null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Researcher-Disqualifications-on-the-Rise-Despite-C/ArticleStandard/Article/detail/523178?ref=25">

    <title>Researcher Disqualifications on the Rise Despite Case Delays</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Researcher-Disqualifications-on-the-Rise-Despite-C/ArticleStandard/Article/detail/523178?ref=25</link>

    <description>The number of clinical-trial investigators overstepping their bounds has grown in the past few years.
    And, says Congress, the US Food and Drug Administration is taking too long to wrap up unresolved
    cases.</description>

    <dc:date>2008-06-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523178null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/A-Guide-to-Near-Infrared-Spectroscopic-Analysis-of/ArticleStandard/Article/detail/523519?ref=25">

    <title>A Guide to Near-Infrared Spectroscopic Analysis of Industrial Manufacturing Processes</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/A-Guide-to-Near-Infrared-Spectroscopic-Analysis-of/ArticleStandard/Article/detail/523519?ref=25</link>

    <description>Near-infrared (NIR) spectroscopy is a simple, quick (&amp;amp;lt;10 second analysis time),
    non-destructive technique that provides multi-constituent analysis on virtually any matrix with levels of accuracy
    and precision that are comparable to primary reference methods. NIR analyses require no sample preparation or
    manipulation and no reagents. This guide provides a practical overview of the critical factors that are useful and
    necessary when developing and implementing NIR spectroscopic methods of analysis in pharmaceutical and chemical
    manufacturing operations.</description>

    <dc:date>2008-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523519null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-CHO-Cell-Culture-Medium-Usin/ArticleStandard/Article/detail/523510?ref=25">

    <title>In Situ Monitoring of CHO Cell Culture Medium Using NIR Spectroscopy</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-CHO-Cell-Culture-Medium-Usin/ArticleStandard/Article/detail/523510?ref=25</link>

    <description>NIR spectroscopy using specialized transmission probes and fiber optics allows real-time in situ
    analysis of bioreactor feed stocks and product. With continuous NIR analysis, metabolic parameters and culture
    media constituents can be better monitored and controlled, which increases CHO cell life and lengthens the
    production phase.</description>

    <dc:date>2008-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523510null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-line-Process-Analysis-of-Residual-Moisture-in-a/ArticleStandard/Article/detail/523514?ref=25">

    <title>In-line Process Analysis of Residual Moisture in a Fluid Bed Granulator&amp;amp;ndash;Dryer Using NIR
    Spectroscopy</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-line-Process-Analysis-of-Residual-Moisture-in-a/ArticleStandard/Article/detail/523514?ref=25</link>

    <description>The authors describe the in-line moisture measurement of a pharmaceutical granulation of lactose,
    microcrystalline cellulose and crospovidone in a fluid bed granulator-dryer using top sprayed granulating liquid. A
    Near-Infrared (NIR) prediction model was developed for moisture on spectra collected during a calibration run.
    Subsequent granulations were analyzed for moisture content real-time throughout the granulation and drying process
    using the FOSS NIR process instrument.</description>

    <dc:date>2008-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523514null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?ref=25">

    <title>Near-Infrared Assay and Content Uniformity of Tablets</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?ref=25</link>

    <description>Near-Infrared (NIR) technique for the determination of content uniformity of tablets provides a fast
    and accurate means of monitoring tablet production that is in step with the FDA Process Analytical Technology (PAT)
    initiatives. The FOSS XDS MasterLab&amp;amp;trade; was used to determine the content uniformity of tablets,
    instrument precision and accuracy. The data showed promising results that could relieve laboratory workload from
    HPLC analysis and bring analysis closer to &amp;#34;real-time&amp;#34; for process monitoring.</description>

    <dc:date>2008-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523511null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Monitoring-Granulation-Drying-using-Near-Infrared-/ArticleStandard/Article/detail/523516?ref=25">

    <title>Monitoring Granulation Drying using Near-Infrared Spectroscopy</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Monitoring-Granulation-Drying-using-Near-Infrared-/ArticleStandard/Article/detail/523516?ref=25</link>

    <description>In situ analysis of residual moisture and methanol using Near-Infrared (NIR) Spectroscopy. A novel
    probe design can reduce the powder-sample density variance such that moisture and solvent levels can be accurately
    modeled and predicted in process. NIR can monitor low levels of residual moisture, alcohol and other process
    constituents to yield better process control and quality management.</description>

    <dc:date>2008-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523516null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation/Assessing-powder-stability/ArticleStandard/Article/detail/522282?ref=25">

    <title>Assessing powder stability</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation/Assessing-powder-stability/ArticleStandard/Article/detail/522282?ref=25</link>

    <description>Some powders appear inherently variable, sensitive to the slightest change in conditions, while others
    are much more forgiving. Stability testing assesses this critical aspect of powder behavior.</description>

    <dc:date>2008-06-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/522282null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation+News/FDA-Issues-Structured-Product-Labeling-Guidance-Sa/ArticleStandard/Article/detail/521245?ref=25">

    <title>FDA Issues Structured Product Labeling Guidance; Says Delays Will Not Occur</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation+News/FDA-Issues-Structured-Product-Labeling-Guidance-Sa/ArticleStandard/Article/detail/521245?ref=25</link>

    <description>The US Food and Drug Administration issued a new guidance Monday on indexing structured product
    labeling. The Center for Biologics Evaluation and Research and the Center for Drug Evaluation and Research will
    begin indexing structured product labeling in the product labeling for human drug and biologic
    products.</description>

    <dc:date>2008-06-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/521245null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/California-Senate-Passes-Bill-That-Would-Amend-the/ArticleStandard/Article/detail/521455?ref=25">

    <title>California Senate Passes Bill That Would Amend the State Confidentiality of Medical Information Act</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/California-Senate-Passes-Bill-That-Would-Amend-the/ArticleStandard/Article/detail/521455?ref=25</link>

    <description>The California Senate passed SB 1096 on May 29, voting to amend the state?s Confidentiality of Medical
    Information Act to allow pharmacies to provide third parties with patient information for the purpose of mailing
    prescription refill reminders and drug information directly to patients.</description>

    <dc:date>2008-06-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/521455null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/SOCMA-Weighs-in-on-Proposed-Legislation-on-Global-/ArticleStandard/Article/detail/521466?ref=25">

    <title>SOCMA Weighs in on Proposed Legislation on Global Warming</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/SOCMA-Weighs-in-on-Proposed-Legislation-on-Global-/ArticleStandard/Article/detail/521466?ref=25</link>

    <description>The Synthetic Organic Chemical Manufacturers Association is evaluating proposed legislation, The
    Climate Security Act of 2008 (S. 3036), which directs the Environmental Protection Agency to establish a program
    for decreasing greenhouse emissions.</description>

    <dc:date>2008-06-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/521466null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Urges-Early-Switch-to-HFA-Propelled-Albuterol-/ArticleStandard/Article/detail/521242?ref=25">

    <title>FDA Urges Early Switch to HFA-Propelled Albuterol Inhalers</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Urges-Early-Switch-to-HFA-Propelled-Albuterol-/ArticleStandard/Article/detail/521242?ref=25</link>

    <description>The US Food and Drug Administration advised patients, caregivers, and healthcare professionals to
    switch to hydrofluoroalkane-propelled albuterol inhalers now because chlorofluorocarbon-propelled inhalers will not
    be available in the US after Dec. 31, 2008.</description>

    <dc:date>2008-06-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/521242null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-to-Acquire-Kosan-L-Pa/ArticleStandard/Article/detail/521822?ref=25">

    <title>Company and People Notes: BMS to Acquire Kosan, L. Patrick Gage Resigns from PDL, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-to-Acquire-Kosan-L-Pa/ArticleStandard/Article/detail/521822?ref=25</link>

    <description>Also, Pall plans expansion in South America, Anthony Clarke joins Alexza Pharmaceuticals,
    more...</description>

    <dc:date>2008-06-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/521822null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-EMEA-and-European-Commission-Set-First-Goals-i/ArticleStandard/Article/detail/521462?ref=25">

    <title>FDA, EMEA, and European Commission Set First Goals in Med Regulation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-EMEA-and-European-Commission-Set-First-Goals-i/ArticleStandard/Article/detail/521462?ref=25</link>

    <description>The transatlantic cooperation of the European Commission, the European Medicines Agency, and the US
    Food and Drug Administration was recognized at the Second Meeting of the Transatlantic Economic Council, held mid
    May in Brussels. The TEC is tasked with overseeing and accelerating government-to-government cooperation to advance
    economic integration between the United States and the European Union.</description>

    <dc:date>2008-06-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/521462null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/European-Commission-Seeks-to-Tighten-the-API-Suppl/ArticleStandard/Article/detail/519118?ref=25">

    <title>European Commission Seeks to Tighten the API Supply Chain</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/European-Commission-Seeks-to-Tighten-the-API-Suppl/ArticleStandard/Article/detail/519118?ref=25</link>

    <description>As part of a larger effort to address drug counterfeiting, the European Commission is seeking to
    tighten manufacturing and related supply-chain requirements for active pharmaceutical ingredients.</description>

    <dc:date>2008-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222008/519118null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/CMOs-are-Planning-for-the-Last-War/ArticleStandard/Article/detail/519119?ref=25">

    <title>CMOs are Planning for the Last War</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/CMOs-are-Planning-for-the-Last-War/ArticleStandard/Article/detail/519119?ref=25</link>

    <description>CMO business models are out of touch with current pharma industry realities. It's time for new
    thinking.</description>

    <dc:date>2008-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222008/519119null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Global-and-US-Biotech-Markets-Show-Strength/ArticleStandard/Article/detail/519117?ref=25">

    <title>Global and US Biotech Markets Show Strength</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Global-and-US-Biotech-Markets-Show-Strength/ArticleStandard/Article/detail/519117?ref=25</link>

    <description>The global and US biotechnology industries performed well in 2007 as each recorded higher revenues and
    inched toward aggregate profitability.</description>

    <dc:date>2008-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222008/519117null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/Innovations-at-INTERPHEX-Part-2/ArticleStandard/Article/detail/522137?ref=25">

    <title>Innovations at INTERPHEX: Part 2</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusive/Innovations-at-INTERPHEX-Part-2/ArticleStandard/Article/detail/522137?ref=25</link>

    <description>New products for sterile filling, quality control, and anticounterfeiting measures gained
    notice.</description>

    <dc:date>2008-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/522137/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/522137null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/Public-Service-Versus-Self-Service/ArticleStandard/Article/detail/522123?ref=25">

    <title>Public Service Versus Self-Service</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/Public-Service-Versus-Self-Service/ArticleStandard/Article/detail/522123?ref=25</link>

    <description>The good, the bad, and the ugly about direct-to-consumer advertising.</description>

    <dc:date>2008-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/522123null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/PDA-Takes-On-Risks-for-Patients/ArticleStandard/Article/detail/522124?ref=25">

    <title>PDA Takes On Risks for Patients</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/PDA-Takes-On-Risks-for-Patients/ArticleStandard/Article/detail/522124?ref=25</link>

    <description>Risk management, and its benefits for patients, plays a big role at the PDA Annual
    Meeting.</description>

    <dc:date>2008-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/522124null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/The-Use-of-Complaining/ArticleStandard/Article/detail/522125?ref=25">

    <title>The Use of Complaining</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/The-Use-of-Complaining/ArticleStandard/Article/detail/522125?ref=25</link>

    <description>Customers complaining lead to some serious explaining.</description>

    <dc:date>2008-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232008/522125null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


